Consolidated Balance Sheet as at 31 March 2014 31 March 2013 1 April 2012 31 March 2014 Restated Restated Note million million Non-current assets Investments at fair value through profit or loss 12 1,495.5 1,200.4 902.0 Total non-current assets 1,495.5 1,200.4 902.0 Current assets Trade and other receivables 1.1 0.2 1.8 Other financial assets 0.8 0.8 Cash and cash equivalents 42.7 172.9 267.9 Total current assets 44.6 173.9 269.7 Total assets 1,540.1 1,374.3 1,171.7 Current liabilities Trade and other payables 13 10.1 12.2 12.7 Other current financial liabilities 0.5 0.5 Loans and borrowings 14 26.9 138.5 Total current liabilities 10.6 39.6 151.2 Total liabilities 10.6 39.6 151.2 Net assets 1,529.5 1,334.7 1,020.5 Equity Ordinary Share capital 15 0.1 0.1 0.1 Share premium 15 1,110.0 992.4 717.6 Retained reserves 419.4 342.2 302.8 Total equity attributable to equity holders of the parent 1,529.5 1,334.7 1,020.5 Total equity 1,529.5 1,334.7 1,020.5 1 Net assets per Ordinary Share pence 11 126.7 120.0 116.3 Net assets per C Share pence 98.7 Comparative information, including relevant Notes, has been restated as a result of applying IFRS 10, including Investment Entities Amendments to IFRS 10, IFRS 12 and IAS 27.
The Net assets per share at 31 March 2013 is that applicable to the 976.4 million Ordinary Shares in issue on the record date of 1 March 2013.
The 140 million Ordinary Shares issued on 27 March 2013 pursuant to the New Ordinary Share Prospectus of 26 February 2013 were not eligible for the second interim dividend of 3.575p.
The accompanying Notes are an integral part of these financial statements.
The financial statements were approved and authorised for issue by the Board of Directors on 20 May 2014, and signed on its behalf by: J Hallam G Picken Director Director 66 H ICL A N N U A L R E PO R T & A C COU N T S 2014
